BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/15/2018 9:50:44 AM | Browse: 1427 | Download: 1995
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 38949
Country Cyprus
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making?
Manuscript Source Invited Manuscript
All Author List Stavros Gkolfinopoulos, Demetris Papamichael, Konstantinos Papadimitriou, Panos Papanastasopoulos, Vassilios Vassiliou and Panteleimon Kountourakis
ORCID
Author(s) ORCID Number
Stavros Gkolfinopoulos http://orcid.org/0000-0003-2470-8620
Demetris Papamichael http://orcid.org/0000-0002-2643-5569
Konstantinos Papadimitriou http://orcid.org/0000-0003-4500-4075
Panos Papanastasopoulos http://orcid.org/0000-0003-4352-881X
Vassilios Vassiliou http://orcid.org/0000-0002-1164-6531
Panteleimon Kountourakis http://orcid.org/0000-0002-1134-6176
Funding Agency and Grant Number
Corresponding Author Panteleimon Kountourakis, MD, PhD, Attending Doctor, Department of Medical Oncology, BOC Oncology Center, 32 Acropoleos Ave, Nicosia 2006, Cyprus. pantelis.kountourakis@bococ.org.cy
Key Words Gastric cancer; Cancer Genome Atlas; Asian Cancer Research Group; Targeted therapy
Core Tip Despite recent advances in cancer therape­utics, the survival of gastric cancer patients with met­astatic disease is dismal due to the complexity of the disease, the constant evolution of tumors and our still limited understanding of its biology. It is evident that a wide spectrum of prognostic and predictive biomarke­rs is needed in order to rationalize our decisions when managing patients with this specific tumor type and ta­ilor our treatment to suit better the individual patient’s unique needs.
Publish Date 2018-07-15 09:50
Citation Gkolfinopoulos S, Papamichael D, Papadimitriou K, Papanast­asopoulos P, Vassiliou V, Kountourakis P. Αdvances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making? World J Gastrointest Oncol 2018; 10(7): 172-183
URL http://www.wjgnet.com/1948-5204/full/v10/i7/172.htm
DOI http://dx.doi.org/10.4251/wjgo.v10.i7.172
Full Article (PDF) WJGO-10-172.pdf
Full Article (Word) WJGO-10-172.doc